These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32064754)

  • 1. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
    Mayer EF; Maron G; Dallas RH; Ferrolino J; Tang L; Sun Y; Danziger-Isakov L; Paulsen GC; Fisher BT; Vora SB; Englund J; Steinbach WJ; Michaels M; Green M; Yeganeh N; Gibson JE; Dominguez SR; Nicholson MR; Dulek DE; Ardura MI; Rajan S; Gonzalez BE; Beneri C; Herold BC
    Am J Transplant; 2020 Aug; 20(8):2133-2142. PubMed ID: 32064754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
    Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
    Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
    Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
    Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
    Cusini A; Béguelin C; Stampf S; Boggian K; Garzoni C; Koller M; Manuel O; Meylan P; Mueller NJ; Hirsch HH; Weisser M; Berger C; van Delden C;
    Am J Transplant; 2018 Jul; 18(7):1745-1754. PubMed ID: 29349869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children.
    Ochfeld E; Balmert LC; Patel SJ; Muller WJ; Kociolek LK
    Transpl Infect Dis; 2019 Oct; 21(5):e13149. PubMed ID: 31332916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
    Mullane KM; Dubberke ER;
    Clin Transplant; 2019 Sep; 33(9):e13564. PubMed ID: 31002420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.
    Ortiz-Balbuena J; Royuela A; Calderón-Parra J; Martínez-Ruiz R; Asensio-Vegas Á; Múñez E; Valencia-Alijo Á; Gutiérrez-Rojas Á; Ussetti P; Cuervas-Mons V; Segovia-Cubero J; Portolés-Pérez J; Ramos-Martínez A
    Transplant Proc; 2021 Dec; 53(10):2826-2832. PubMed ID: 34772488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
    Barbar R; Hayden R; Sun Y; Tang L; Hakim H
    Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients.
    Haeusler GM; Lehrnbecher T; Agyeman PKA; Loves R; Castagnola E; Groll AH; van de Wetering M; Aftandilian CC; Phillips B; Chirra KM; Schneider C; Dupuis LL; Sung L
    Eur J Cancer; 2022 Aug; 171():1-9. PubMed ID: 35696884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
    Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
    Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxigenic
    Keegan J; Buchan BW; Ledeboer NA; Zhou Z; Hong JC; Graham MB; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):287-291. PubMed ID: 32933595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
    Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-onset Clostridium difficile infection among solid organ transplant recipients.
    Donnelly JP; Wang HE; Locke JE; Mannon RB; Safford MM; Baddley JW
    Am J Transplant; 2015 Nov; 15(11):2970-7. PubMed ID: 26484839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
    Ciricillo J; Haslam D; Blum S; Kim MO; Liu C; Paulsen G; Courter J; Danziger-Isakov L
    Transpl Infect Dis; 2016 Oct; 18(5):706-713. PubMed ID: 27492796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ganetsky A; Han JH; Hughes ME; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Luger SM; Mangan JK; Martin ME; Smith J; Freyer CW; Gilmar C; Schuster M; Stadtmauer EA; Porter DL
    Clin Infect Dis; 2019 May; 68(12):2003-2009. PubMed ID: 30256954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients.
    Neofytos D; Kobayashi K; Alonso CD; Cady-Reh J; Lepley D; Harris M; Desai N; Kraus E; Subramanian A; Treadway S; Ostrander D; Thompson C; Marr K
    Transpl Infect Dis; 2013 Apr; 15(2):134-41. PubMed ID: 23173772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post-transplant.
    Guzman L; Qiu F; Kalil AC; Mercer DF; Langnas A; Florescu DF
    Transpl Infect Dis; 2018 Apr; 20(2):e12858. PubMed ID: 29427406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.